Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuhuang Jiangze capsule add-on therapy for type 2 diabetes inadequately controlled with metformin
ChiCTR1900021765Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Fuhuang Jiangze capsule in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoint: Change in hemoglobin A1c from baseline to week 12. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
Fuhuang Jiangze capsule
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900021765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021765.